Literature DB >> 8428160

On the existence of suppressor cells.

R Arnon1, D Teitelbaum.   

Abstract

Immunological suppression is one of the important aspects which govern the regulation of the immune response. Clonal deletion, clonal anergy and the activity of suppressor cells were proposed as mechanisms leading to this phenomenon. In this review we provide evidence for the existence of suppressor (Ts) cells and their role in autoimmunity in general and particularly in the system of experimental allergic encephalomyelitis (EAE). Ts cell lines and clones that downregulate in-vivo the autoimmune response are described. These results, as well as other recent advances in the understanding of Ts cells regulatory mechanisms and the molecular structures recognized by these cells, lead to the conclusion that Ts cells do exist and that they constitute a distinctive cell type in regard to their function and specificity.

Entities:  

Mesh:

Year:  1993        PMID: 8428160     DOI: 10.1159/000236379

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  4 in total

Review 1.  Immunologic tolerance in renal transplantation.

Authors:  D A Shoskes
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

2.  Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat.

Authors:  T Smith; A K Hewson; C I Kingsley; J P Leonard; M L Cuzner
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  In healthy primates, circulating autoreactive T cells mediate autoimmune disease.

Authors:  C P Genain; D Lee-Parritz; M H Nguyen; L Massacesi; N Joshi; R Ferrante; K Hoffman; M Moseley; N L Letvin; S L Hauser
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

Review 4.  From Mysterious Supernatant Entity to miRNA-150 in Antigen-Specific Exosomes: a History of Hapten-Specific T Suppressor Factor.

Authors:  Włodzimierz Ptak; Katarzyna Nazimek; Philip W Askenase; Krzysztof Bryniarski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-02-18       Impact factor: 4.291

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.